Following the MPP-ViiV agreement on
#dolutegravir in late 2020, we're pleased to announce progress in the fight against
#HIV in Azerbaijan🇦🇿, Belarus🇧🇾, Kazakhstan🇰🇿 & Malaysia🇲🇾👇
✅ In Belarus & Kazakhstan, the volumes of DTG procured by national HIV programmes can cover 78% and 86% of people on
#ART respectively.
✅ Azerbaijan is making strides to reach 65%of people on ART with DTG treatments this year🎉
✅Malaysia is planning to accelerate the transition to TLD starting from 2025.
These achievements were made possible by price reductions ↘️ of over 90% and are a result of the dedication of many, incl communities, healthcare professionals & governments.
Read our statement 👉
bit.ly/3VZFnak
#GlobalHealth #Access2Meds